These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2191052)

  • 1. Interleukin-6: molecular pathophysiology.
    Sehgal PB
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):2S-6S. PubMed ID: 2191052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues.
    Sehgal PB
    Mol Biol Med; 1990 Apr; 7(2):117-30. PubMed ID: 2188060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic and clinical aspects of IL-6].
    Nakajima K; Hirano T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6: historical background, genetics and biological significance.
    Wolvekamp MC; Marquet RL
    Immunol Lett; 1990; 24(1):1-9. PubMed ID: 2197219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical aspects of interleukin 6.
    Hirano T; Akira S; Taga T; Kishimoto T
    Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and role of interleukin 6 in wounded human epithelial keratinocytes.
    Sugawara T; Gallucci RM; Simeonova PP; Luster MI
    Cytokine; 2001 Sep; 15(6):328-36. PubMed ID: 11594800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene regulation by interleukin 6.
    Fey GH; Hattori M; Hocke G; Brechner T; Baffet G; Baumann M; Baumann H; Northemann W
    Biochimie; 1991 Jan; 73(1):47-50. PubMed ID: 2031958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.
    Teunissen MB; Koomen CW; de Waal Malefyt R; Wierenga EA; Bos JD
    J Invest Dermatol; 1998 Oct; 111(4):645-9. PubMed ID: 9764847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of interleukin-6 in epithelial cells.
    Krueger J; Ray A; Tamm I; Sehgal PB
    J Cell Biochem; 1991 Apr; 45(4):327-34. PubMed ID: 2045425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.
    Groves RW; Rauschmayr T; Nakamura K; Sarkar S; Williams IR; Kupper TS
    J Clin Invest; 1996 Jul; 98(2):336-44. PubMed ID: 8755642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin 6 (IL-6)].
    Dohi K; Iwano M; Horii Y
    Nihon Rinsho; 1992 Dec; 50(12):2916-20. PubMed ID: 1491446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4.
    Derocq JM; Segui M; Poinot-Chazel C; Minty A; Caput D; Ferrara P; Casellas P
    FEBS Lett; 1994 Apr; 343(1):32-6. PubMed ID: 7909299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes.
    Sawamura D; Meng X; Ina S; Sato M; Tamai K; Hanada K; Hashimoto I
    J Immunol; 1998 Nov; 161(10):5633-9. PubMed ID: 9820543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
    Wittmann M; Purwar R; Hartmann C; Gutzmer R; Werfel T
    J Invest Dermatol; 2005 Jun; 124(6):1225-33. PubMed ID: 15955098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
    Biffl WL; Moore EE; Moore FA; Peterson VM
    Ann Surg; 1996 Nov; 224(5):647-64. PubMed ID: 8916880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
    Lu C; Kerbel RS
    J Cell Biol; 1993 Mar; 120(5):1281-8. PubMed ID: 8436594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diseases associated with cytokine dysregulation].
    Kishimoto T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):724-34. PubMed ID: 8371004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.